Jian Pan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Benign Prostatic Hyperplasia

Prostate Cancer

Top Venues

Journal of clinical medicine

Molecular oncology

European journal of nuclear medicine and molecular imaging

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Bangwei Fang, Yu Wei, Jian Pan, Tingwei Zhang, Dingwei Ye, Yao Zhu
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 12 (2) (2023)
Bangwei Fang, Yu Wei, Jian Pan, Tingwei Zhang, Dingwei Ye, Yao Zhu
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 12 (2) (2023)
Jian Pan, Jinou Zhao, Xudong Ni, Bin Zhu, Xiaoxin Hu, Qifeng Wang, Yu Wei, Tingwei Zhang, Hualei Gan, Beihe Wang, Junlong Wu, Shaoli Song, Chang Liu, Dingwei Ye, Yao Zhu
Heterogeneity of [ 68 Ga]Ga-PSMA-11 PET/CT in metastatic castration-resistant prostate cancer: genomic characteristics and association with abiraterone response. European journal of nuclear medicine and molecular imaging (2023)
Yu Wei, Tingwei Zhang, Beihe Wang, Jian Pan, Shengming Jin, Bangwei Fang, Weijie Gu, Xiaojian Qin, Bo Dai, Guowen Lin, Hualei Gan, Junlong Wu, Dingwei Ye, Yao Zhu
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. Molecular oncology (2023)
Bangwei Fang, Yu Wei, Jian Pan, Tingwei Zhang, Dingwei Ye, Yao Zhu
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 12 (2) (2023)
Bangwei Fang, Yu Wei, Jian Pan, Tingwei Zhang, Dingwei Ye, Yao Zhu
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 12 (2) (2023)
Jian Pan, Jinou Zhao, Xudong Ni, Hualei Gan, Yu Wei, Junlong Wu, Tingwei Zhang, Qifeng Wang, Stephen J Freedland, Beihe Wang, Shaoli Song, Dingwei Ye, Chang Liu, Yao Zhu
The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancer. Molecular oncology 16 (22) (2022)
Jian Pan, Jun Wang, Yu Wei, Tingwei Zhang, Sheng Zhang, Ding-Wei Ye, Yao Zhu
Combination of body mass index and albumin predicts the survival in metastatic castration-resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials. Cancer medicine 10 (19) (2021)